JP2012019784A5 - - Google Patents

Download PDF

Info

Publication number
JP2012019784A5
JP2012019784A5 JP2011133825A JP2011133825A JP2012019784A5 JP 2012019784 A5 JP2012019784 A5 JP 2012019784A5 JP 2011133825 A JP2011133825 A JP 2011133825A JP 2011133825 A JP2011133825 A JP 2011133825A JP 2012019784 A5 JP2012019784 A5 JP 2012019784A5
Authority
JP
Japan
Prior art keywords
gene
genes
subject
biological sample
fatigue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011133825A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012019784A (ja
JP5990871B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011133825A priority Critical patent/JP5990871B2/ja
Priority claimed from JP2011133825A external-priority patent/JP5990871B2/ja
Publication of JP2012019784A publication Critical patent/JP2012019784A/ja
Publication of JP2012019784A5 publication Critical patent/JP2012019784A5/ja
Application granted granted Critical
Publication of JP5990871B2 publication Critical patent/JP5990871B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011133825A 2010-06-18 2011-06-16 疲労の判定方法 Active JP5990871B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011133825A JP5990871B2 (ja) 2010-06-18 2011-06-16 疲労の判定方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010138894 2010-06-18
JP2010138894 2010-06-18
JP2011133825A JP5990871B2 (ja) 2010-06-18 2011-06-16 疲労の判定方法

Publications (3)

Publication Number Publication Date
JP2012019784A JP2012019784A (ja) 2012-02-02
JP2012019784A5 true JP2012019784A5 (enExample) 2014-07-03
JP5990871B2 JP5990871B2 (ja) 2016-09-14

Family

ID=45774603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011133825A Active JP5990871B2 (ja) 2010-06-18 2011-06-16 疲労の判定方法

Country Status (1)

Country Link
JP (1) JP5990871B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104630136B (zh) * 2013-11-15 2019-10-01 中国科学院广州生物医药与健康研究院 一种制备诱导多能性干细胞的方法以及该方法中所使用的组合物及其应用
JP6623162B2 (ja) * 2014-08-27 2019-12-18 株式会社ウイルス医科学研究所 疲労に関与する因子及びその利用
KR101643353B1 (ko) * 2014-10-10 2016-07-27 서울대학교산학협력단 운동 스트레스 진단용 조성물 및 이의 용도
JP7405400B2 (ja) * 2019-11-20 2023-12-26 Necソリューションイノベータ株式会社 核酸分子およびその用途
JP7655721B2 (ja) * 2020-12-18 2025-04-02 花王株式会社 疲労マーカー及びそれを用いた疲労の検出方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005124565A (ja) * 2003-09-29 2005-05-19 Sogo Ikagaku Kenkyusho:Kk 新規神経ペプチド及びその利用
JP2007228878A (ja) * 2006-03-01 2007-09-13 Hitachi Ltd 慢性疲労症候群の診断方法
JP2008054590A (ja) * 2006-08-31 2008-03-13 Hitachi High-Technologies Corp 運動ストレス状態の評価方法
US20100047188A1 (en) * 2008-08-04 2010-02-25 Idera Pharmaceuticals, Inc. Modulation of toll-like receptor 8 expression by antisense oligonucleotides
MX2011004674A (es) * 2008-11-04 2011-05-25 Idera Pharmaceuticals Inc Modulacion de la expresion del receptor 4 tipo larga distancia por oligonucleotidos antisentido.

Similar Documents

Publication Publication Date Title
Clauss et al. MicroRNAs as biomarkers for acute atrial remodeling in marathon runners (The miRathon study–a sub-study of the Munich marathon study)
Wang et al. A meta-analysis of dysregulated miRNAs in coronary heart disease
JP2016513094A5 (enExample)
EP2812693B1 (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
WO2020234729A1 (en) Deep proteome markers of human biological aging and methods of determining a biological aging clock
Soplinska et al. MicroRNAs as biomarkers of systemic changes in response to endurance exercise—a comprehensive review
Vidusa et al. Role of endomyocardial biopsy in diagnostics of myocarditis
JP2016500110A5 (enExample)
Becker et al. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach
Leuenberger et al. Circulating miRNAs: a new generation of anti-doping biomarkers
JP2012019784A5 (enExample)
US9708669B2 (en) Method for detecting genes sensitive to low-level ionizing radiation
BR112020023259A2 (pt) biomarcadores de acidente vascular cerebral no sangue
Linares-Rodríguez et al. The Predictive Value of Blood-Derived Exosomal miRNAs as Biomarkers in Breast Cancer: A Systematic Review
WO2017120285A1 (en) METHODS OF USING miRNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEVELOPMENTAL DISORDERS
Shaikh et al. Arrhythmogenic Right Ventricular Cardiomyopathy: A Comprehensive Review
Huang et al. Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients
Song et al. Identification of risk genes related to myocardial infarction and the construction of early SVM diagnostic model
JP7065862B2 (ja) 癌の再発および進行のモニタリング
RU2569459C1 (ru) Способ дифференциальной диагностики этиологии хронической сердечной недостаточности
Bilal et al. Circulation of miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction
CN105087758A (zh) 一种肺癌预后预测miRNA检测试剂盒
Parent et al. Noninvasive Tools for Monitoring Acute Cardiac Allograft Rejection: State of the Art
WO2017135850A8 (ru) Способ диагностики заболевания, сопровождающегося повышенной гибелью клеток, и набор для его осуществления
Omar et al. Leucocytic DNA methylation of interleukin-6 promoter reduction in pre-hypertensive young adults